user

Interferon beta-1a in relapsing-remitting multiple sclerosis

被引：2
|
作者：
Blumhardt, L [1 ]
机构：
[1] Univ Nottingham, Div Clin Neurol, Nottingham NG7 2UH, England
来源：
HOSPITAL MEDICINE | 1999年 / 60卷 / 03期
关键词：
D O I：
10.12968/hosp.1999.60.3.1065
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The accumulated results from multiple trials have unequivocally demonstrated beneficial effects of interferon beta-1a on disease activity in relapsing-remitting multiple sclerosis, both for clinical and magnetic resonance endpoints. New data suggest that low doses administered once weekly ore relatively ineffective and that higher, more Frequent doses are required for optimal benefit.
引用
收藏
页码：192 / 195
页数：4
相关论文
共 50 条
  • [1] Interferon beta-1a in relapsing-remitting multiple sclerosis: A meta-analysis
    Blumhardt, LD
    NEUROLOGY, 1999, 52 (06) : A498 - A498
  • [2] Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
    Vazquez Gomez, Lazaro Aurelio
    Hidalgo Mesa, Carlos
    Broche Perez, Yunier
    Valdes Morales, Yanet
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2022, 20 (05): : 825 - 833
  • [3] Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis
    Munschauer, FE
    Stuart, WH
    CLINICAL THERAPEUTICS, 1997, 19 (05) : 868 - 882
  • [4] Effects of statins on intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis
    Rudick, R.
    Pace, A.
    Panzara, M.
    Rani, S.
    Schrock, J.
    Calabresi, F.
    Confavreux, C.
    Galetta, S.
    Lublin, F.
    Radue, E. W.
    Stuart, W.
    Weinstock-Guttman, B.
    Wynn, D.
    MULTIPLE SCLEROSIS, 2007, 13 : S57 - S57
  • [5] Effect of Intramuscular Interferon beta-1a on Gray Matter Atrophy in Relapsing-Remitting Multiple Sclerosis
    Nakamura, Kunio
    Rudick, Richard
    Lee, Jar-Chi
    Foulds, Pamela
    Fisher, Elizabeth
    NEUROLOGY, 2010, 74 (09) : A407 - A407
  • [6] Effect of interferon beta-1a on grey matter atrophy progression in relapsing-remitting multiple sclerosis
    Zivadinov, R
    Locatelli, L
    Srinivasaraghavan, B
    Ukmar, M
    Bratina, A
    Maggiore, C
    Bosco, A
    Grop, A
    Pozzi-Mucelli, R
    Catalan, M
    Zorzon, M
    MULTIPLE SCLEROSIS, 2005, 11 (01): : 115 - 115
  • [7] Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis
    De Stefano, Nicola
    Curtin, Francois
    Stubinski, Bettina
    Blevins, Gregg
    Drulovic, Jelena
    Issard, Delphine
    Shotekov, Penko
    Gasperini, Claudio
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) : 888 - 892
  • [8] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Dupuy, Sheena L.
    Khalid, Fariha
    Healy, Brian C.
    Bakshi, Sonya
    Neema, Mohit
    Tauhid, Shahamat
    Bakshi, Rohit
    BMC MEDICAL IMAGING, 2016, 16
  • [9] The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosis
    Dupuy, S.
    Khalid, F.
    Healy, B. C.
    Bakshi, S.
    Neema, M.
    Tauhid, S.
    Bakshi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 232 - 232
  • [10] Emerging Methods for Evaluating the Effectiveness of Intramuscular Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis
    Foley, John F.
    Barnes, Christopher J.
    Nair, Kavita V.
    JOURNAL OF MANAGED CARE PHARMACY, 2013, 19 (01): : S16 - S23
12345